[go: up one dir, main page]

FR1730M - Nouvelle composition de collyre. - Google Patents

Nouvelle composition de collyre.

Info

Publication number
FR1730M
FR1730M FR885027A FR885027A FR1730M FR 1730 M FR1730 M FR 1730M FR 885027 A FR885027 A FR 885027A FR 885027 A FR885027 A FR 885027A FR 1730 M FR1730 M FR 1730M
Authority
FR
France
Prior art keywords
eye drops
new composition
composition
new
drops
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR885027A
Other languages
English (en)
Inventor
Charles Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR885027A priority Critical patent/FR1730M/fr
Priority to US250770A priority patent/US3232833A/en
Priority to GB1794/63A priority patent/GB1029034A/en
Application granted granted Critical
Publication of FR1730M publication Critical patent/FR1730M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR885027A 1962-01-17 1962-01-17 Nouvelle composition de collyre. Expired FR1730M (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR885027A FR1730M (fr) 1962-01-17 1962-01-17 Nouvelle composition de collyre.
US250770A US3232833A (en) 1962-01-17 1963-01-11 Heparin containing compositions
GB1794/63A GB1029034A (en) 1962-01-17 1963-01-15 Pharmaceutical compositions for the treatment of inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR885027A FR1730M (fr) 1962-01-17 1962-01-17 Nouvelle composition de collyre.

Publications (1)

Publication Number Publication Date
FR1730M true FR1730M (fr) 1963-03-18

Family

ID=8770598

Family Applications (1)

Application Number Title Priority Date Filing Date
FR885027A Expired FR1730M (fr) 1962-01-17 1962-01-17 Nouvelle composition de collyre.

Country Status (3)

Country Link
US (1) US3232833A (fr)
FR (1) FR1730M (fr)
GB (1) GB1029034A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000043A1 (fr) * 1987-07-08 1989-01-12 Martin Kludas Agent ophtalmique ainsi que ses compositions, et procede de traitement de la cornee
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3548052A (en) * 1964-10-27 1970-12-15 Canada Packers Ltd Heparin compositions and methods of using same
US3510561A (en) * 1965-05-20 1970-05-05 Canada Packers Ltd Sulfone-enhanced heparin absorption through mucous membranes
US3482014A (en) * 1966-06-29 1969-12-02 Canada Packers Ltd Orally active heparin and method for making and using same
US3546338A (en) * 1967-03-30 1970-12-08 American Cyanamid Co Heparin composition
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
US4024237A (en) * 1975-08-04 1977-05-17 Bertram Eichel Novel compositions for establishing environmental conditions favorable to oral leucocytes
US4377573A (en) * 1978-01-06 1983-03-22 Leveen Harry H Method of control of gastrointestinal bleeding
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
GB2317182B (en) * 1996-09-11 2000-11-01 Johnson & Johnson Medical Sulfated polysaccharides and uses thereof in medical treatment
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1024072A (fr) * 1949-09-14 1953-03-27 Hoffmann La Roche Procédé pour la préparation d'un sel de l'acide héparinique
US3112246A (en) * 1959-09-28 1963-11-26 Hoffmann La Roche Stabilization of heparin preparations
US3062716A (en) * 1960-02-08 1962-11-06 Applic Chimiques D Etudes Et D Method of treating hemorrhoids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000043A1 (fr) * 1987-07-08 1989-01-12 Martin Kludas Agent ophtalmique ainsi que ses compositions, et procede de traitement de la cornee
US5055298A (en) * 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix

Also Published As

Publication number Publication date
GB1029034A (en) 1966-05-11
US3232833A (en) 1966-02-01

Similar Documents

Publication Publication Date Title
FR1730M (fr) Nouvelle composition de collyre.
CH473214A (it) Composizione lubrificante
FR3237M (fr) Nouvelle composition analgésique.
FR89144E (fr) Composition lubrifiante
FR1372717A (fr) Composition lubrifiante
AT248002B (de) Ölzusammensetzung
FR1503509A (fr) Composition nouvelle de résines de styrène-acrylonitrile
BE612273A (fr) Nouvelle composition ferromagnétique.
OA01963A (fr) Nouvelle forme de lingot.
FR1318733A (fr) Nouvelle composition cosmétique
BR6346411D0 (pt) Composicao antielmintica
FR1354589A (fr) Composition lubrifiante perfectionnée
AT259110B (de) Ölzusammensetzung
FR1323772A (fr) Composition explosive nouvelle
FR1867M (fr) Composition nouvelle destinée notamment au traitement de la cholestérolémie.
FR1319251A (fr) étui notamment pour feuillets
FR1331444A (fr) Nouvelle casquette
FR1369723A (fr) Nouvelle composition photosensible
FR1277368A (fr) Miroir anti-buée
FR1368647A (fr) Nouvelle émulsion photodéveloppable
BE597862A (fr) Nouvelle machine de boulangerie.
FR1330861A (fr) Nouvelle brique de parement
FR2875M (fr) Esters de 6-hydroxy-17-éthylenedioxy-3α,5α-cycloandrostane.
FR1450983A (fr) Nouvelle émulsion photodéveloppable
FR1454M (fr) Nouvelle pénicilline.